FDA posts list of potential problem drugs

WASHINGTON (AP) -- The government has begun posting online a list of medications under investigation for potential problems. It's part of an effort to improve communication with doctors and patients on prescription drug safety.

The first list simply names 20 medications and the potential safety issue for each. But it provides no indication of how widespread or serious the problems might be.

The head of the Food and Drug Administration's drug safety office says the agency is trying to tell the public what it's working on "at the earliest stage."

Drugs will be placed on the list based on reports the FDA receives regularly from hospitals, doctors and patients. If FDA safety reviewers determine that a reported problem with a particular drug deserves a closer look, that medication will be on the list.

The FDA is also hoping the list with generate more reports from medical providers.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to webmaster@wvlt-tv.com. Please provide detailed information.

powered by Disqus


6450 Papermill Drive Knoxville, TN 37919 Phone - (865) 450-8888; Fax - (865) 450-8869
Copyright © 2014 WVLT-TV Inc. - Designed by Gray Digital Media - Powered by Clickability 27911154 - local8now.com/a?a=27911154
Gray Television, Inc.